# Randomized MMF Withdrawal in Systemic Lupus Erythematosus (SLE)

> **NCT01946880** · PHASE2 · TERMINATED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 102 (actual)

## Conditions studied

- Systemic Lupus Erythematosus
- SLE

## Interventions

- **DRUG:** Mycophenolate Mofetil
- **DRUG:** Hydroxychloroquine or Chloroquine
- **DRUG:** Prednisone

## Key facts

- **NCT ID:** NCT01946880
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-11-20
- **Primary completion:** 2019-07-03
- **Final completion:** 2019-07-03
- **Target enrollment:** 102 (ACTUAL)
- **Why stopped:** Slow enrollment.
- **Last updated:** 2020-08-17

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01946880

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01946880, "Randomized MMF Withdrawal in Systemic Lupus Erythematosus (SLE)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01946880. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*